Sign In to Follow Application
View All Documents & Correspondence

Medical Material Medical Separation Membrane And Blood Purifier

Abstract: The purpose of the present invention is to provide a medical material capable of suppressing adhesion of platelets and proteins even when in contact with biological components such as blood for an extended period of time.-The present invention provides a medical material that is a copolymer comprising hydrophobic units and hydrophilic units in which the hydrophobic units have a C2-20 terminal alkyl group in a side chain, the static contact angle of water in the copolymer is at least 30° and less than 70°, and the glass transition temperature of the copolymer exists at only one point in the range from 45°

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
07 March 2019
Publication Number
11/2019
Publication Type
INA
Invention Field
BIO-MEDICAL ENGINEERING
Status
Email
patent@depenning.com
Parent Application
Patent Number
Legal Status
Grant Date
2021-12-10
Renewal Date

Applicants

TORAY INDUSTRIES, INC.
1-1, Nihonbashi-Muromachi 2-chome, Chuo-ku, Tokyo 1038666

Inventors

1. USHIRO, Suguru
c/o Shiga Plant, Toray Industries, Inc., 1-1, Sonoyama 1-chome, Otsu-shi, Shiga 5208558
2. HAYASHI, Akihiro
c/o Shiga Plant, Toray Industries, Inc., 1-1, Sonoyama 1-chome, Otsu-shi, Shiga 5208558
3. UENO, Yoshiyuki
c/o Shiga Plant, Toray Industries, Inc., 1-1, Sonoyama 1-chome, Otsu-shi, Shiga 5208558

Specification

WE CLAIM:
>
1. A medical material which is a copolymer comprising a
hydrophobic unit and a hydrophilic unit,
wherein
the hydrophobic unit has a terminal alkyl group having 2 to 20 carbon atoms in a side chain,
a static contact angle of water on the copolymer is 30 degrees or more and less than 70 degrees, and
the copolymer has only one glass transition temperature in a range of 45°C or higher and lower than 90°C.
2. The medical material according to claim 1, wherein the hydrophobic unit is an alkyl carboxylic acid vinyl ester unit.
3. The medical material according to claim 1 or 2, wherein the hydrophilic unit is a vinylpyrrolidone unit.
4. The medical material according to any one of claims 1 to 3, wherein
the static contact angle of water on the copolymer is 34 degrees or more and less than 50 degrees, and the copolymer has* only one glass transition

temperature in a range of from 70°C or higher and lower than 88°C.
5. A medical separation membrane in which the medical material according to any one of claims 1 to 4 is bonded or attached to a surface of a membrane including a hydrophobic polymer.
6. The medical separation membrane according to claim 5, wherein
the static contact angle of water on the hydrophobic polymer is 70 degrees or more and less than 160 degrees, and
the glass transition temperature of the hydrophobic
<, i
polymer is 50°C or higher and lower than 250°C.
7. The medical separation membrane according to claim 5 or 6, wherein the hydrophobic polymer includes a polymer selected from the group consisting of a polysulfone-based polymer, a polymethacrylate-based polymer, a polyacrylate-based polymer, a polyester-based polymer and a polystyrene-based polymer.
8. A blood purifier including the medical separation membrane according to any one of claims 5 to 7.

Documents

Application Documents

# Name Date
1 201947008872.pdf 2019-03-07
2 201947008872-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [07-03-2019(online)].pdf 2019-03-07
3 201947008872-STATEMENT OF UNDERTAKING (FORM 3) [07-03-2019(online)].pdf 2019-03-07
4 201947008872-PROOF OF RIGHT [07-03-2019(online)].pdf 2019-03-07
5 201947008872-PRIORITY DOCUMENTS [07-03-2019(online)].pdf 2019-03-07
6 201947008872-POWER OF AUTHORITY [07-03-2019(online)].pdf 2019-03-07
7 201947008872-FORM 1 [07-03-2019(online)].pdf 2019-03-07
8 201947008872-DRAWINGS [07-03-2019(online)].pdf 2019-03-07
9 201947008872-DECLARATION OF INVENTORSHIP (FORM 5) [07-03-2019(online)].pdf 2019-03-07
10 201947008872-COMPLETE SPECIFICATION [07-03-2019(online)].pdf 2019-03-07
11 201947008872-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [07-03-2019(online)].pdf 2019-03-07
12 abstract 201947008872.jpg 2019-03-13
13 Correspondence by Agent_Form 1_20-03-2019.pdf 2019-03-20
14 201947008872-FORM 3 [08-08-2019(online)].pdf 2019-08-08
15 201947008872-FORM 3 [17-12-2019(online)].pdf 2019-12-17
16 201947008872-FORM 18 [13-04-2020(online)].pdf 2020-04-13
17 201947008872-FORM 3 [18-11-2020(online)].pdf 2020-11-18
18 201947008872-OTHERS [30-07-2021(online)].pdf 2021-07-30
19 201947008872-FORM-26 [30-07-2021(online)].pdf 2021-07-30
20 201947008872-FORM 3 [30-07-2021(online)].pdf 2021-07-30
21 201947008872-FER_SER_REPLY [30-07-2021(online)].pdf 2021-07-30
22 201947008872-CLAIMS [30-07-2021(online)].pdf 2021-07-30
23 201947008872-certified copy of translation [30-07-2021(online)].pdf 2021-07-30
24 201947008872-ABSTRACT [30-07-2021(online)].pdf 2021-07-30
25 201947008872-FER.pdf 2021-10-17
26 201947008872-FORM 3 [03-12-2021(online)].pdf 2021-12-03
27 201947008872-PatentCertificate10-12-2021.pdf 2021-12-10
28 201947008872-IntimationOfGrant10-12-2021.pdf 2021-12-10
29 201947008872-RELEVANT DOCUMENTS [30-09-2023(online)].pdf 2023-09-30

Search Strategy

1 2021-05-1511-27-56E_16-05-2021.pdf

ERegister / Renewals

3rd: 17 Dec 2021

From 22/08/2019 - To 22/08/2020

4th: 17 Dec 2021

From 22/08/2020 - To 22/08/2021

5th: 17 Dec 2021

From 22/08/2021 - To 22/08/2022

6th: 06 Jul 2022

From 22/08/2022 - To 22/08/2023

7th: 06 Jul 2023

From 22/08/2023 - To 22/08/2024

8th: 18 Jul 2024

From 22/08/2024 - To 22/08/2025

9th: 03 Jul 2025

From 22/08/2025 - To 22/08/2026